Research Progress of SGLT2 Inhibitors in Cancer Treatment by Miao X, Zhang J, Huang W, Wang Y, Jin A, Cao J, Zhao Z

Subjects: Get full text

Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials by Lucia Scisciola, Vittoria Cataldo, Fatemeh Taktaz, Rosaria Anna Fontanella, Ada Pesapane, Puja Ghosh, Martina Franzese, Armando Puocci, Antonella De Angelis, Liberata Sportiello, Raffaele Marfella, Raffaele Marfella, Michelangela Barbieri

Subjects: “…SGLT2 inhibitors (SGLT2i)…”
Get full text

Safety of SGLT2 inhibitors in very elderly diabetic type 2 patients in real life by Ramón Baeza-Trinidad, José Daniel Mosquera-Lozano

Subjects: Get full text

The metabolic model of heart failure: the role of sodium glucose co-transporter-2 (SGLT-2) inhibition by Muhammad Saad, Umut Gomceli, Pranav Ravi, Andrisael G Lacoste, Neil Shah, Timothy J Vittorio

Subjects: “…SGLT-2 inhibitors…”
Get full text

The Effect Of SGLT-2 Inhibitors On Improving Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. by Wasef Sayeh, Sudheer Dhoop, Sahithi Chinnam, Rayna Patel, Azizullah Beran, Megan Karrick, Anas Renno, Ali Nawras

Subjects: “…SGLT-2…”
Get full text

A review on the medicinal chemistry of sodium glucose co-transporter 2 inhibitors (SGLT2-I): Update from 2010 to present by Jonali Ramani, Harshil Shah, Vivek K. Vyas, Manmohan Sharma

Subjects: Get full text

Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors by Lucia Scisciola, Fatemeh Taktaz, Rosaria Anna Fontanella, Ada Pesapane, Surina, Vittoria Cataldo, Puja Ghosh, Martina Franzese, Armando Puocci, Pasquale Paolisso, Concetta Rafaniello, Raffaele Marfella, Maria Rosaria Rizzo, Emanuele Barbato, Marc Vanderheyden, Michelangela Barbieri

Subjects: “…SGLT2…”
Get full text

Navigating the therapeutic landscape of SGLT2 inhibitors in diabetes management: exploring efficacy and emerging concerns by Farazul Hoda, Harsha Negi, Digvijaya Saini, Mawrah Arshad, Sidra Zayed, Mukesh Kumar Raut, Mohammad Anwar Habib, Mohd Akhtar, Abul Kalam Najmi

Subjects: Get full text

Toxicological assessment of SGLT2 inhibitors metabolites using in silico approach by JÉSSICA B. DE JESUS, RAISSA A. DA CONCEIÇÃO, THAYNÁ R. MACHADO, MARIA L.C. BARBOSA, THAISA F.S. DOMINGOS, LUCIO M. CABRAL, CARLOS R. RODRIGUES, BÁRBARA ABRAHIM-VIEIRA, ALESSANDRA M.T. DE SOUZA

Subjects: Get full text

Three Levels of Disease Modification with SGLT-2 Inhibitors: Holy Grail in Vasculopathy by Archit Dhaiya; Rajeev Sharma; Nagendra Bhoopathy; Rajeev Agarwal

Subjects: “…Hyperglycemia, SGLT-2, Inhibitors.…”
Get full text

SGLT2 inhibitors and the changing landscape for treatment of diabetes by Liu S, Lam A, Wazir A, Cheema AN

Subjects: Get full text

Ketoacidosis without significantly hyperglycaemia - is it possible? by Michał Budzyński, Joanna Pekar, Justyna Magdalena Skolarczyk, Monika Tadla, Katarzyna Skórzyńska-Dziduszko

Subjects: “…SGLT2 inhibitors…”
Get full text

Case Report: Diabetic ketoacidosis after co-administration of empagliflozin and probenecid [version 2; peer review: 2 approved, 1 approved with reservations] by Niamh Reidy, William P. Martin, Tomás Ahern, Justin Low

Subjects: Get full text

Safety and effects of SGLT-2 inhibitor use among LVAD patients with type 2 diabetes mellitus by Matthew Cagliostro, Prabhjot Hundal, Peter Ting, Sonika Patel, Sangita Sudarshan, Jordan Thomas, Kathleen Morris, Donna M. Mancini, Noah Moss, Anuradha Lala, Ashwin Ravichandran, Sumeet S. Mitter

Subjects: “…SGLT2 inhibitors (SGLT2i)…”
Get full text

Sodium–glucose cotransporter‐2 inhibitors induced euglycemic diabetic ketoacidosis: Two case reports and a review of the literature by Zouheir Ibrahim Bitar, Ossama Sajeh Maadarani, Fawaz Alabdali, Ahmed Teama, Walid Elsawah, Mohammed Jaber Mohsen, Mahmoud Mostafa Elzoueiry

Subjects: Get full text

An Overview of the Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Hematological Parameters in Diabetic Patients by Ghada Ahmed, Mohammed Abed, Fawaz Alassaf

Subjects: “…sglt2 inhibitors…”
Get full text

SGLT-2 inhibitors in chronic peritoneal dialysis patients: a follow-up study by Jia-Wen Lai, Charles C.N. Wang, Che-Yi Chou

Subjects: Get full text

SGLT 2 inhibitors: Antidiabetic agents with promising effects beyond glucose control by Canan Ersoy

Subjects: “…sglt2 inhibitor…”
Get full text

The effect of low and high dose empagliflozin on HbA1c and lipid profile in type 2 diabetes mellitus: A real-world data by Serhat Özçelik, Mehmet Çelik, Aşkı Vural, Bünyamin Aydın

Subjects: Get full text

Unmasking of normocalcemic primary hyperparathyroidism after sodium-glucose cotransporter-2 inhibitor initiation by Christodoulos Dolapsakis, Emmanouil Karofylakis, Stamatios Chalvatzis

Subjects: “…sglt2 inhibitors…”
Get full text